Apolipoprotein B-containing lipoproteins in atherogenesis

2025/01/02 by Jan Borén, Chris J. Packard, Christoph J. Binder · 1 voice
Immunology and Microbiology · Medicine · #Atherosclerosis and Cardiovascular Diseases #Diabetes, Cardiovascular Risks, and Lipoproteins #Lipoproteins and Cardiovascular Health

paper · doi:10.1038/s41569-024-01111-0

crossref issued 2025/01/02 · crossref published 2025/01/02 · crossref published-online 2025/01/02 · openalex publication_date 2025/01/02 · crossref created 2025/01/02 · crossref deposited 2025/05/20 · crossref published-print 2025/06/01 · openalex created_date 2025/10/10 · crossref indexed 2026/08/01 · openalex updated_date 2026/08/01

Citations

• Oxidation-specific epitopes are dominant targets of innate natural antibodies in mice and humans
• Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus Panel
• T cell subsets and functions in atherosclerosis
• Association Between Immune Checkpoint Inhibitors With Cardiovascular Events and Atherosclerotic Plaque
• 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk
• Heart Disease and Stroke Statistics—2022 Update: A Report From the American Heart Association
• The multifaceted impact of complement on atherosclerosis
• Integrated single-cell analysis-based classification of vascular mononuclear phagocytes in mouse and human atherosclerosis

Discussions

• doi.org/10.1038/s415... @enilev.bsky.social my enilev🪔mom Mr @tonymoroney.bsky.social 🌐 #BOSCh @bsky.app #blueSky #bigdata #ML #usa #CyberSecurity #Technology #uk #bitcoin #genAI #ai #eUrope # [bsky, 0 points, 0 comments]